Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CR8F | ISIN: US47103J1051 | Ticker-Symbol:
NASDAQ
06.06.25 | 22:00
26,210 US-Dollar
+5,86 % +1,450
1-Jahres-Chart
JANUX THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
JANUX THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur JANUX THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.05.Leerink cuts Janux Therapeutics price target to $89, keeps Outperform2
09.05.Janux Therapeutics GAAP EPS of -$0.381
08.05.Janux Therapeutics, Inc. - 10-Q, Quarterly Report2
08.05.Janux Therapeutics, Inc. - 8-K, Current Report1
05.05.Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross' Stock Picks with Huge Upside Potential1
JANUX THERAPEUTICS Aktie jetzt für 0€ handeln
05.05.Janux Therapeutics begins phase 1b trial for prostate cancer therapy1
06.03.Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently1
28.02.Cantor Fitzgerald maintains $200 target on Janux Therapeutics stock4
27.02.Janux Therapeutics GAAP EPS of -$0.36 beats by $0.071
27.02.Janux Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
27.02.Janux Therapeutics, Inc. - 10-K, Annual Report-
27.02.Janux Therapeutics, Inc. - 8-K, Current Report-
24.02.Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now1
11.12.24Navigating 10 Analyst Ratings For Janux Therapeutics4
03.12.24Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences1.026CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up...
► Artikel lesen
02.12.24Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC178SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
06.11.24Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights197SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
07.08.24Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights268SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1